Clinical Trial Update: Low-protein Infant Formula With Partial or Extensive Proteinhydrolysate 4 Year Follow-up [NA]

View source ↗

Summary

This entry reports a four-year follow-up update of a trial evaluating a low-protein infant formula with partially or extensively hydrolyzed protein in infants w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disturbance of Growth

Snippet

Sponsor: HiPP GmbH & Co. Vertrieb KG | Conditions: Disturbance of Growth | NA | Status: COMPLETED